PEDRO ENRIQUE DORLHIAC LLACER
Projetos de Pesquisa
Unidades Organizacionais
Instituto Central, Hospital das Clínicas, Faculdade de Medicina - Médico
2 resultados
Resultados de Busca
Agora exibindo 1 - 2 de 2
conferenceObject NILOTINIB SHOWS SUSTAINED BENEFIT COMPARED WITH IMATINIB IN PATIENTS (PTS) WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP): ENESTND 4-YEAR FOLLOW-UP (F/U)(2013) HOCHHAUS, A.; SAGLIO, G.; LARSON, R.; ROSTI, G.; FLINN, Ian; GOH, Y.; LLACER, P.; PORKKA, K.; KANDA, Y.; STENKE, L.; KEMP, C.; FAN, X.; MENSSEN, H.; KANTARJIAN, H.; HUGHES, T.conferenceObject NILOTINIB INDUCES DEEPER MOLECULAR RESPONSES VS CONTINUED IMATINIB IN PATIENTS WITH PH plus CHRONIC MYELOID LEUKEMIA (CML) WITH DETECTABLE DISEASE AFTER=2 YEARS ON IMATINIB: ENESTCMR 12-MONTH RESULTS(2012) CERVANTES, C.; HUGHES, T.; ETIENNE, G.; SOUZA, C. A. De; LLACER, P. E. Dorlhiac; SCHWARER, A.; LEBER, B.; LIPTON, J.; SPECTOR, N.; REYNOLDS, J.; COLLINS, L.; SZCZUDLO, T.; REA, D.